Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients with Diabetes

NCT06331923 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10168

Last updated 2025-03-27

No results posted yet for this study

Summary

The goal of this multi-center, pragmatic, randomized controlled trial is to assess the effectiveness of continuous glucose monitoring (CGM) compared with conventional monitoring in enhancing surgical outcomes for diabetic patients. The main questions it aims to answer are:

* To assess the effectiveness of CGM compared with conventional monitoring in reducing the comprehensive complication index (CCI) for patients with diabetes or impaired glucose tolerance (IGT) within 30 days after surgery.
* To analyze the impact of different age groups, types of surgery, preoperative levels of HbA1c, and preoperative 24h glycemic variations on the improvement of surgical outcomes under the CGM model.

Participants will receive CGM prescribed by the attending physician for at least 6 hours before surgery. Glucose monitoring should be continued until the 7th day after surgery or discharge.

The investigators will compare conventional monitoring group to see if CGM could reduce the CCIs for patients with diabetes or impaired glucose tolerance within 30 days after surgery.

Conditions

  • Comprehensive Complication Index

Interventions

DEVICE

Continuous glucose monitoring (CGM) device

Continuous glucose monitoring (CGM) will be prescribed by the attending physician for at least 6 hours before surgery. The supervising nurse will educate the patient and their family on the correct wearing and connection of the CGM device. The calibration frequency and interval of glucose monitoring devices before and after surgery should be determined according to institutional treatment guidelines and the requirements of the monitoring device used. Intraoperative glucose calibration should be done immediately upon entering the operating room, immediately after skin incision, every 2 hours after skin incision, and at the end of wound closure. Glucose monitoring should be continued until the 7th day after surgery or discharge.

Sponsors & Collaborators

  • Peking University International Hospital

    collaborator OTHER
  • Wang Jing Hospital

    collaborator OTHER
  • ZhuHai Hospital

    collaborator OTHER
  • Beijing Hospital

    collaborator OTHER_GOV
  • Siyang County Hospital of Traditional Chinese Medicine

    collaborator UNKNOWN
  • Second Hospital of Shanxi Medical University

    collaborator OTHER
  • Henan Provincial Chest Hospital

    collaborator OTHER
  • Fuzhou First Hospital

    collaborator UNKNOWN
  • Pinggu Hospital of Beijing Traditional Chinese Medicine Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Anhui University of Chinese Medicine

    collaborator OTHER
  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER
  • Mindong Hospital of Ningde

    collaborator UNKNOWN
  • The Fifth Hospital of Xiamen

    collaborator UNKNOWN
  • People's Hospital of Ningxia Hui Autonomous Region

    collaborator OTHER
  • The First People's Hospital of Changzhou

    collaborator OTHER
  • The Fifth hospital of Deyang

    collaborator UNKNOWN
  • Suzhou Municipal Hospital

    collaborator OTHER
  • Tang-Du Hospital

    collaborator OTHER
  • Yiyang Central Hospital

    collaborator UNKNOWN
  • First Affiliated Hospital of Xinjiang Medical University

    collaborator OTHER
  • Peng Ding Shan Shi Zhong Yi Yi Yuan

    collaborator UNKNOWN
  • Yueyang Central Hospital

    collaborator OTHER
  • The First People's Hospital of Lianyungang

    collaborator OTHER
  • Haimen District Traditional Chinese Medicine Hospital

    collaborator UNKNOWN
  • The 910th Hospital

    collaborator UNKNOWN
  • The Second Affiliated Hospital of Zhejiang Chinese Medical University

    collaborator OTHER
  • Beijing Tiantan Hospital

    collaborator OTHER
  • Affiliated Hospital of Jiangsu University

    collaborator OTHER
  • Liaocheng People's Hospital

    collaborator OTHER
  • Beijing Chao Yang Hospital

    collaborator OTHER
  • Jilin City Hospital of Chemical Industry

    collaborator UNKNOWN
  • Creen Hospital-465

    collaborator UNKNOWN
  • Wuhan Central Hospital

    collaborator OTHER
  • Air Force Military Medical University, China

    collaborator OTHER
  • Shanghai Tong Ren Hospital

    collaborator OTHER
  • Beijing Anzhen Hospital

    collaborator OTHER
  • Emergency General Hospital

    collaborator OTHER
  • Beijing Tongren Hospital

    collaborator OTHER
  • Civil Aviation General Hospital

    collaborator OTHER
  • Peking University Shougang Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Anhui Medical University

    collaborator OTHER
  • Chinese PLA Central Hospital

    collaborator UNKNOWN
  • Beijing Tsinghua Chang Gung Hospital

    lead OTHER

Principal Investigators

  • Lan Yao · Peking University International Hospital

  • Hui Q Xu · Wangjing Hospital, China Academy of Chinese Medical Sciences

  • Yan Liu · ZhuHai Hospital

  • Qi Pan · Beijing Hospital

  • Jian H Jia · Siyang County Hospital of Traditional Chinese Medicine

  • Yi K Zhu · Second Hospital of Shanxi Medical University

  • Ke F Shi · Henan Provincial Chest Hospital

  • Fang F Zhang · Fuzhou First Hospital

  • Xiu Zh Wang · Pinggu District Hospital of Traditional Chinese Medicine

  • Feng Hong · The First Affiliated Hospital of Anhui University of Chinese Medicine

  • Ying J Hao · The First Affiliated Hospital of Zhengzhou University

  • Yi Q Cai · Mindong Hospital of Ningde

  • Lin Shen · Heze Hospital of Traditional Chinese Medicine

  • Jin L Liang · The Fifth Hospital of Xiamen

  • Zhen Wang · People's Hospital of Ningxia Hui Autonomous Region

  • Hong W Ye · The First People's Hospital of Changzhou

  • Qin Wang · The Fifth hospital of Deyang

  • Jian P Qiu · Suzhou Municipal Hospital

  • Bo Liao · Tang-Du Hospital

  • Xin J Liu · Yiyang Central Hospital

  • Guo Sh Gu · Anhui No.2 Provincial People's Hospital

  • Li Quan · First Affiliated Hospital of Xinjiang Medical University

  • Li R Ma · Peng Ding Shan Shi Zhong Yi Yi Yuan

  • Zhi B Zhao · The First People's Hospital of Lianyungang

  • Xin Lu · Haimen District Traditional Chinese Medicine Hospital

  • Feng Zhou · Yueyang Central Hospital

  • Xiao D Yin · Zhe Cheng TCM Hospital

  • Li T Zhang · The 910th Hospital

  • Yu Zh He · The Second Affiliated Hospital of Zhejiang Chinese Medical University

  • Xiao M Zhang · The first People's Hospital of Zhengzhou

  • Yu H Jiang · Beijing Tiantan Hospital

  • Peng Jiang · Affiliated Hospital of Jiangsu University

  • Xiao Y Li · The First Affiliated Hospital of Zhengzhou University

  • Zhi H Liu · Liaocheng People's Hospital Zhiheng Liu

  • Jin C Yang · Beijing Chao Yang Hospital

  • Xue L Zhu · The People's Hospital of Nanchuan, Chongqing

  • Wen T Si · Zhengzhou Orthopaedic Hospital

  • Lei Ning · Jilin City Hospital of Chemical Industry

  • Li H Su · Creen Hospital-465

  • Zhong J Wang · Wuhan Central Hospital

  • Li P Ma · Beijing Anzhen Hospital

  • Yu H Xu · Air Force Military Medical University, China

  • Jiang M Yu · Tong Ren hospital Shanghai Jiao Tong university school of medicine

  • Qing H Cheng · Emergency General Hospital

  • Hui J Wang · Beijing Tongren Hospital, CMU

  • Jun Wu · Heilongjiang provincial hospital

  • Jun T Duan · Civil Aviation General Hospital

  • Zheng G Guo · Peking University Shougang Hospital

  • Xin Kuang · The People's Hospital of Longhua, Shenzhen

  • Chang J Yu · The First Affiliated Hospital of Anhui Medical University

  • Feng Liang · Chinese PLA Central Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-12
Primary Completion
2025-10-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06331923 on ClinicalTrials.gov